Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Concomitant Left Atrial Appendage Closure Outcomes and Cost: A Multi-institutional Cohort Analysis.

Hawkins RB, Clark SS, Mehaffey JH, Rich JB, Speir AM, Quader M, Yarboro LT, Ailawadi G.

J Surg Res. 2019 Dec 31;248:137-143. doi: 10.1016/j.jss.2019.11.030. [Epub ahead of print]

PMID:
31901640
2.

Resilience and sustainability: Similarities and differences in environmental management applications.

Marchese D, Reynolds E, Bates ME, Morgan H, Clark SS, Linkov I.

Sci Total Environ. 2018 Feb 1;613-614:1275-1283. doi: 10.1016/j.scitotenv.2017.09.086. Epub 2017 Sep 26.

PMID:
28962075
3.
4.

Recent advances in the molecular genetics of malignant gliomas disclose targets for antitumor agent perillyl alcohol.

da Fonseca CO, Landeiro JA, Clark SS, Quirico-Santos T, da Costa Carvalho Mda G, Gattass CR.

Surg Neurol. 2006;65 Suppl 1:S1:2-1:8; discussion S1:8-1:9. Review.

PMID:
16427438
5.

Anti-leukemia effect of perillyl alcohol in Bcr/Abl-transformed cells indirectly inhibits signaling through Mek in a Ras- and Raf-independent fashion.

Clark SS, Zhong L, Filiault D, Perman S, Ren Z, Gould M, Yang X.

Clin Cancer Res. 2003 Oct 1;9(12):4494-504.

7.
8.

Perillyl alcohol selectively induces G0/G1 arrest and apoptosis in Bcr/Abl-transformed myeloid cell lines.

Sahin MB, Perman SM, Jenkins G, Clark SS.

Leukemia. 1999 Oct;13(10):1581-91.

10.
12.

Nonrandom cytogenetic changes accompany malignant progression in clonal lines abelson virus-infected lymphocytes.

Clark SS, Liang Y, Reedstrom CK, Wu SQ.

Blood. 1994 Dec 15;84(12):4301-9.

PMID:
7994046
13.

Simultaneous expression of RBTN-2 and BCR-ABL oncogenes in a T-ALL with a t(11;14)(p13;q11) and a late-appearing Philadelphia chromosome.

Fizzotti M, Chen EY, Link MP, Carroll AJ, Foroni L, Rabbitts TH, Crist WM, Clark SS.

Leukemia. 1994 Jul;8(7):1124-30.

PMID:
8035604
14.

Allogeneic T-cell clones able to selectively destroy Philadelphia chromosome-bearing (Ph1+) human leukemia lines can also recognize Ph1- cells from the same patient.

Oettel KR, Wesly OH, Albertini MR, Hank JA, Iliopolis O, Sosman JA, Voelkerding K, Wu SQ, Clark SS, Sondel PM.

Blood. 1994 Jun 1;83(11):3390-402.

PMID:
8193377
15.

BCR-ABL and v-abl oncogenes induce distinct patterns of thymic lymphoma involving different lymphocyte subsets.

Clark SS, Chen E, Fizzotti M, Witte ON, Malkovska V.

J Virol. 1993 Oct;67(10):6033-46.

16.

Simultaneous demonstration of the Philadelphia chromosome in T, B, and myeloid cells.

MacKinney AA Jr, Clark SS, Borcherding W, Fizzotti M, Hong R.

Am J Hematol. 1993 Sep;44(1):48-52.

PMID:
7688179
17.

Analysis of T cell receptor beta and gamma genes from peripheral blood, regional lymph node and tumor-infiltrating lymphocyte clones from melanoma patients.

Albertini MR, Nicklas JA, Chastenay BF, Hunter TC, Albertini RJ, Clark SS, Hank JA, Sondel PM.

Cancer Immunol Immunother. 1991;32(5):325-30.

PMID:
1825620
18.

Molecular relapse in chronic myelogenous leukemia patients after bone marrow transplantation detected by polymerase chain reaction.

Sawyers CL, Timson L, Kawasaki ES, Clark SS, Witte ON, Champlin R.

Proc Natl Acad Sci U S A. 1990 Jan;87(2):563-7.

19.

P185BCR-ABL in two patients with late appearing Philadelphia chromosome-positive acute nonlymphocytic leukemia.

Najfeld V, Cuttner J, Figur A, Kawasaki ES, Witte ON, Clark SS.

Leukemia. 1989 Dec;3(12):841-6.

PMID:
2685476
20.
21.

Molecular pathogenesis of Ph-positive leukemias.

Clark SS, Crist WM, Witte ON.

Annu Rev Med. 1989;40:113-22. Review.

PMID:
2658742
22.

Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro.

Kawasaki ES, Clark SS, Coyne MY, Smith SD, Champlin R, Witte ON, McCormick FP.

Proc Natl Acad Sci U S A. 1988 Aug;85(15):5698-702.

23.

Expression of a distinctive BCR-ABL oncogene in Ph1-positive acute lymphocytic leukemia (ALL).

Clark SS, McLaughlin J, Timmons M, Pendergast AM, Ben-Neriah Y, Dow LW, Crist W, Rovera G, Smith SD, Witte ON.

Science. 1988 Feb 12;239(4841 Pt 1):775-7.

PMID:
3422516
24.

Unique forms of the abl tyrosine kinase distinguish Ph1-positive CML from Ph1-positive ALL.

Clark SS, McLaughlin J, Crist WM, Champlin R, Witte ON.

Science. 1987 Jan 2;235(4784):85-8.

PMID:
3541203
26.

Analysis of associative recognition determinants on class I H-2Kb mutant molecules.

Clark SS, Geier S, Nathenson SG, Forman J.

Immunogenetics. 1985;22(4):391-7. No abstract available.

PMID:
2414216
27.

Functional aspects of class I MHC molecule domains.

Clark SS, Forman J.

Surv Immunol Res. 1984;3(2-3):179-83. No abstract available.

PMID:
6201986
28.

Allogeneic and associative recognition determinants of H-2 molecules.

Clark SS, Forman J.

Transplant Proc. 1983 Dec;15(4):2090-2.

PMID:
6200976
29.

Expression and function of transplantation antigens with altered or deleted cytoplasmic domains.

Zuniga MC, Malissen B, McMillan M, Brayton PR, Clark SS, Forman J, Hood L.

Cell. 1983 Sep;34(2):535-44.

PMID:
6604582
30.

Structure function relationship of class I MHC molecules.

Clark SS, Forman J.

Surv Immunol Res. 1983;2(3):203-6. No abstract available.

PMID:
6201978
31.

Attrition of schistosomes in an irradiation-attenuated cercarial immunization model of Schistosoma mansoni.

Stek M Jr, Dean DA, Clark SS.

Am J Trop Med Hyg. 1981 Sep;30(5):1033-8.

PMID:
7283001
32.
33.

Schistosoma mansoni: immunization of cynomolgus monkeys by injection of irradiated schistosomula.

Murrell KD, Clark SS, Dean DA, Vannier WE.

Exp Parasitol. 1979 Dec;48(3):415-20. No abstract available.

PMID:
116865
34.

Fibroma of tunica albuginea.

Marlett MM, Clark SS.

Urology. 1979 Oct;14(4):381-3.

PMID:
494467
35.

Cell-mediated immune competence in patients with prostatic carcinoma.

Stefani SS, Menon M, Canning JR, Clark SS.

J Urol. 1978 Oct;120(4):431-4.

PMID:
702665
37.

Massive scrotal and occult preputial metastases from carcinoma of the prostate.

Ray B, Sharifi R, Clark SS.

Br J Urol. 1978 Apr;50(2):143. No abstract available.

PMID:
754854
38.

Neurofibromatosis of the bladder in children: case report and literature review.

Clark SS, Marlett MM, Prudencio RF, Dasgupta TK.

J Urol. 1977 Oct;118(4):654-6.

PMID:
916068
39.

Massive inguinoscrotal bladder herniation.

Ray B, Darwish ME, Baker RJ, Clark SS.

J Urol. 1977 Aug;118(2):330-1. No abstract available.

PMID:
894822
40.

Occult sclerosing carcinoma of the thyroid.

Clark SS, Childers JC, Poulos E.

South Med J. 1976 Dec;69(12):1611-3.

PMID:
1019681
41.

Hemangioma of scrotum.

Ray B, Clark SS.

Urology. 1976 Nov;8(5):502-5. No abstract available.

PMID:
982743
42.

Treatment of extensive renal calculi with extracorporeal surgery and autotransplantation.

Andersen OS, Clark SS, Marlett MM, Jonasson O.

Urology. 1976 May;7(5):465-9.

PMID:
1274001
43.

Priapism: evaluation of treatment regimens.

Darwish ME, Atassi B, Clark SS.

J Urol. 1974 Jul;112(1):92-4. No abstract available.

PMID:
4835084
44.

Electrolyte disturbance associated with jejunal conduit.

Clark SS.

J Urol. 1974 Jul;112(1):42-7. No abstract available.

PMID:
4600661
45.

Clitoroplasty: experience during a 19-year period.

Kumar H, Kiefer JH, Rosenthal IE, Clark SS.

J Urol. 1974 Jan;111(1):81-4. No abstract available.

PMID:
4813559
46.

Lactic dehydrogenase isozymes in benign and malignant prostatic tissues.

Srinivasan V, Keil E, Villalba R, Baron T, Clark SS.

Invest Urol. 1973 Nov;11(3):244-7. No abstract available.

PMID:
4127178
47.

Assessment of potency with the Doppler flowmeter.

Malvar T, Baron T, Clark SS.

Urology. 1973 Oct 4;2(4):396-400. No abstract available.

PMID:
4270958
48.

Single-layer bowel anastomosis in intestinal conduit surgery.

Misurec R, Clark SS.

J Urol. 1973 Jun;109(6):996-8. No abstract available.

PMID:
4575815
49.

Retroperitoneal conduit. Indications and uses.

Clark SS.

Urology. 1973 May;1(5):420-4. No abstract available.

PMID:
4772814
50.

Supplemental Content

Loading ...
Support Center